Authorizes pharmacists to dispense HIV pre-exposure and post-exposure prophylaxis.
Summary
Bill A00358 amends the education law to authorize licensed pharmacists in New York to dispense both HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). The bill allows pharmacists to provide a starter pack of PEP for up to seven days and a supply of PrEP for a minimum of thirty days and a maximum of sixty days. The dispensing of these medications will be regulated by the commissioner of health in consultation with relevant health authorities, ensuring that pharmacists meet specific training and patient assessment requirements before dispensing these medications.
Impact
The passage of this bill will significantly expand access to HIV prevention medications by allowing pharmacists to dispense PrEP and PEP, which were previously limited to physicians and certified nurse practitioners. This change aims to enhance public health efforts in preventing HIV transmission, particularly in communities at higher risk. It will also necessitate updates to existing regulations and training programs for pharmacists to ensure compliance with the new dispensing authority.
Sentiment
The sentiment around Bill A00358 appears to be generally supportive, as it aligns with public health goals to reduce HIV transmission rates. However, there may be concerns regarding the adequacy of training for pharmacists and the potential for improper dispensing without thorough patient assessments. The lack of recorded votes or committee discussions suggests that the bill may still be in early stages of consideration.
Contention
Notable points of contention may arise regarding the training requirements for pharmacists and the safeguards needed to ensure that patients receive appropriate care. Some stakeholders may argue that allowing pharmacists to dispense these medications could lead to inadequate patient evaluations, while others may advocate for the increased accessibility that this bill provides. The balance between accessibility and patient safety is likely to be a key area of debate.
Requiring health insurance policies to provide coverage for pre-exposure prophylaxis and post-exposure prophylaxis HIV medication and associated laboratory tests and patient visits.
Authorizes pharmacists to dispense HIV prophylaxis without individual prescription under certain circumstances; mandates prescription benefits coverage.
Establishing statewide standards governing the use of HIV post-exposure prophylaxis, permitting a pharmacist to initiate such medication to certain patients, providing civil liability protections to pharmacists who initiate prophylactic therapy to patients for post-exposure to human immunodeficiency virus.
Authorizes pharmacists to dispense HIV prophylaxis without individual prescription under certain circumstances; mandates prescription benefits coverage.
Authorizes pharmacists to dispense HIV prophylaxis without individual prescription under certain circumstances; mandates prescription benefits coverage.
Authorizes pharmacists to dispense HIV prophylaxis without individual prescription under certain circumstances; mandates prescription benefits coverage.
Coverage without cost-sharing requirement of immunization for routine use without a prescription, Minnesota Science-Based Vaccine Advisory Council establishment, and appropriation
Coverage without cost-sharing of immunizations for routine use without a prescription mandated, Minnesota Science-Based Vaccine Advisory Council established, advisory council duties established, and money appropriated.